Home › Trial NCT01650467
Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms
- Trial IDNCT01650467
- StatusWithdrawn
- PhaseN/A
- Study typeObservational
- SponsorCentre Hospitalier Universitaire de Nīmes
- Enrollment—
- Start date2014-12
- ConditionsLeukemia, Myeloid, Chronic-Phase
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.